CORMORANT ASSET MANAGEMENT, LP – Sarepta Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$22.10M
portfolio value
Sarepta Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | 0.00% | 200K shares | 22.10M | $110.54 | 200K |
| Q2 2021 | share | Decrease | -100.00% | -70K shares | -5.21M | $77.74 | 0 |
| Q1 2021 | share | 0.00% | 0 shares | -6.71M | $74.53 | 70K | |
| Q4 2020 | share | Decrease | -17.65% | -15K shares | -3K | $170.49 | 70K |
| Q3 2020 | share | Decrease | -22.73% | -25K shares | -5.7M | $140.43 | 85K |
| Q2 2020 | share | Decrease | -26.67% | -40K shares | 2.96M | $160.34 | 110K |
| Q1 2020 | share | Decrease | -40.00% | -100K shares | -17.58M | $97.82 | 150K |
| Q4 2019 | share | Increase | +12.76% | 28.3K shares | 15.56M | $129.04 | 250K |
| Q3 2019 | share | Decrease | -1.47% | -3.3K shares | -17.49M | $75.32 | 221.7K |
| Q2 2019 | share | Decrease | -25.00% | -75K shares | -1.56M | $151.95 | 225K |
| Q1 2019 | share | Increase | +233.33% | 210K shares | 25.93M | $119.19 | 300K |
| Q4 2018 | share | Increase | 0.00% | 90K shares | 9.82M | $109.13 | 90K |